Adjunct Laboratory Tests in the Diagnosis of Early-Onset Neonatal Sepsis

Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, 750 Welch Road, Suite 315, Stanford, Palo Alto, CA 94304, USA. <>
Clinics in perinatology (Impact Factor: 2.44). 06/2010; 37(2):421-38. DOI: 10.1016/j.clp.2009.12.001
Source: PubMed


Early-onset sepsis remains a major diagnostic problem in neonatal medicine. Definitive diagnosis depends on cultures of blood or other normally sterile body fluids. Abnormal hematological counts, acute-phase reactants, and inflammatory cytokines are neither sensitive nor specific, especially at the onset of illness. Combinations of measurements improve diagnostic test performance, but the optimal selection of analytes has not been determined. The best-established use of these laboratory tests is for retrospective determination that an infant was not infected, based on failure to mount an acute-phase response over the following 24 to 48 hours.

Download full-text


Available from: William Benitz, Jan 15, 2015
  • Source
    • "The combined measurement of a cytokine (IL-6 or IL-8) and CRP is currently considered as the most reliable method with the highest sensitivity and specificity for early diagnosis of both EONS and LONS [27]. IL-6 detects sepsis at an early stage of infection with a maximum of serum levels as early as 1-2 hours after inflammation reaction has started, potentially even prior to onset of clinical symptoms [28]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Neonatal sepsis remains a burden problem by showing minimal initial symptoms of subtle character, nonspecific manifestation, and diagnostic pitfalls. The clinical course can be fulminant and fatal if treatment is not commenced promptly. It is therefore crucial to establish early diagnosis and initiate adequate therapy. Besides clinical symptoms, the most reliable laboratory markers in establishing diagnosis is currently the combined measurement of CRP and a cytokine (IL-6 and IL-8). Due to their different kinetics, a diagnostic gap might occur and thus withholding antimicrobial therapy in clinical suspicion of infection is not acceptable. We therefore need parameters which unerringly differentiate between infants in need for antimicrobial therapy and those who are not. Flow cytometry promises to be a useful tool in this field, allowing the determination of different cellular, dissolved, and functional pathophysiological components of sepsis. Despite technical and methodical advances in flow cytometry, its use in clinical routine is still limited. Advantages and disadvantages of promising new parameters in diagnosis of sepsis performed by flow cytometry, particularly CD64, HLA-DR, and apoptosis, are reviewed here. The necessity of tests to be used as an "ideal" parameter is presented.
    Full-text · Article · Feb 2013 · International Journal of Pediatrics
  • Source
    • "Because of the high negative predictive value, screening panels may produce a significant decrease in the use of antimicrobial agents. With their use, fewer neonates would receive antimicrobial agents, and antibiotic treatment could be more confidently discontinued earlier.12,14 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite the advances in perinatal and neonatal care and use of newer potent antibiotics, the incidence of neonatal sepsis remains high and the outcome is still severe. For years, investigators have sought a test or panel of tests able to identify septic neonates accurately and rapidly in order to obtain an early diagnosis and develop a specific effective treatment for a successful outcome. In addition to the standard procedures (blood, CSF, and urine cultures), such panels have included a combination of haematological investigations (total, differential and immature cell counts), and levels of acute-phase reactants (principally CRP and procalcitonin), and cytokines (such as IL-6 or neutrophil CD64). Furthermore, the science of proteomics and genomics has been applied to the search for bio-markers, production of protein profiles and genetic polymorphisms that can rapidly help the prediction, early diagnosis, and treatment of human diseases, but, for now, data are as yet insufficient to confirm their validity.
    Full-text · Article · Feb 2011 · Pediatric reports
  • Source

    Full-text · Article · Jan 2010
Show more